European Society For Medical Oncology
Sep 28, 2016
Merck Focuses its Research on Hard to Treat Cancers
Merck is a leading science and technology company, and has many projects that are involved in research to find treatments for diseases that are hard to treat. Keeping in view with this agenda, Merck has announced that the new research that has been conducted from their marketed and pipeline compounds will be present...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
